117 related articles for article (PubMed ID: 30001838)
1. miR-141-3p commonly regulates human UGT1A isoforms via different mechanisms.
Tatsumi N; Tokumitsu S; Nakano M; Fukami T; Nakajima M
Drug Metab Pharmacokinet; 2018 Aug; 33(4):203-210. PubMed ID: 30001838
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach.
Papageorgiou I; Court MH
Biochem Pharmacol; 2017 Aug; 137():93-106. PubMed ID: 28433553
[TBL] [Abstract][Full Text] [Related]
3. Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.
Dluzen DF; Sun D; Salzberg AC; Jones N; Bushey RT; Robertson GP; Lazarus P
J Pharmacol Exp Ther; 2014 Mar; 348(3):465-77. PubMed ID: 24399855
[TBL] [Abstract][Full Text] [Related]
4. Regulation of UGT1A expression by miR-298 in human livers from the Han Chinese population and in human cell lines.
Wang P; Nie YL; Wang SJ; Yang LL; Yang WH; Li JF; Li XT; Zhang LR
Epigenomics; 2018 Jan; 10(1):43-57. PubMed ID: 29172698
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.
Papageorgiou I; Court MH
Biochem Pharmacol; 2017 Dec; 146():199-213. PubMed ID: 28962835
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome association analysis identifies miR-375 as a major determinant of variable acetaminophen glucuronidation by human liver.
Papageorgiou I; Freytsis M; Court MH
Biochem Pharmacol; 2016 Oct; 117():78-87. PubMed ID: 27531059
[TBL] [Abstract][Full Text] [Related]
7. Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes.
Fujiwara R; Nakajima M; Oda S; Yamanaka H; Ikushiro S; Sakaki T; Yokoi T
J Pharm Sci; 2010 Jan; 99(1):442-54. PubMed ID: 19475557
[TBL] [Abstract][Full Text] [Related]
8. Regulation of uridine diphosphate-glucuronosyltransferase 1A expression by miRNA-214-5p and miRNA-486-3p.
Paulusch S; Kalthoff S; Landerer S; Jansen C; Schierwagen R; Klein S; Trebicka J; Strassburg CP
Epigenomics; 2021 Feb; 13(4):271-283. PubMed ID: 33432840
[No Abstract] [Full Text] [Related]
9. Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms.
Fujiwara R; Nakajima M; Yamanaka H; Nakamura A; Katoh M; Ikushiro S; Sakaki T; Yokoi T
Drug Metab Dispos; 2007 May; 35(5):747-57. PubMed ID: 17293379
[TBL] [Abstract][Full Text] [Related]
10. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T
Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers.
Aueviriyavit S; Furihata T; Morimoto K; Kobayashi K; Chiba K
Drug Metab Pharmacokinet; 2007 Oct; 22(5):391-8. PubMed ID: 17965524
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: effects of UGT-UGT interactions.
Nakajima M; Yamanaka H; Fujiwara R; Katoh M; Yokoi T
Drug Metab Dispos; 2007 Sep; 35(9):1679-86. PubMed ID: 17576806
[TBL] [Abstract][Full Text] [Related]
15. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.
Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M
Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920
[TBL] [Abstract][Full Text] [Related]
16. Potential Regulation of UGT2B10 and UGT2B7 by miR-485-5p in Human Liver.
Sutliff AK; Shi J; Watson CJW; Hunt MS; Chen G; Zhu HJ; Lazarus P
Mol Pharmacol; 2019 Dec; 96(6):674-682. PubMed ID: 31554697
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional characterization of UDP-glucuronosyltransferase 1A in cynomolgus macaques.
Uno Y; Takahira R; Murayama N; Ishii Y; Ikenaka Y; Ishizuka M; Yamazaki H; Ikushiro S
Biochem Pharmacol; 2018 Sep; 155():172-181. PubMed ID: 29944869
[TBL] [Abstract][Full Text] [Related]
18. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
[TBL] [Abstract][Full Text] [Related]
19. Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro.
Bellemare J; Rouleau M; Girard H; Harvey M; Guillemette C
Drug Metab Dispos; 2010 Oct; 38(10):1785-9. PubMed ID: 20610558
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of functional UDP-glucuronosyltransferases 1A and 2B in common marmosets.
Uno Y; Uehara S; Inoue T; Kawamura S; Murayama N; Nishikawa M; Ikushiro S; Sasaki E; Yamazaki H
Biochem Pharmacol; 2020 Feb; 172():113748. PubMed ID: 31830470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]